Single administration of Rejuva reduced fat mass and improved glycemia in the well-validated diet-induced obesity (DIO) mouse model
Rejuva also prevented weight and glycemic rebound after semaglutide withdrawal
Data provide first demonstration that Rejuva treatment has potential to mimic natural release of GLP-1 from pancreas
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.